Molecular Classification
Transporter (system, not a single protein), Other (multi-protein complex/process)
Other Names
Fatty acid mitochondrial transport system, Carnitine shuttle, Mitochondrial fatty acid import system, Carnitine-dependent fatty acid transport
Disease Roles
Inherited metabolic disorders (e.g., carnitine deficiency syndromes)Cardiomyopathy (in context of transporter deficiencies)[3]Hypoketotic hypoglycemia[3]

Carnitine shuttle system Overview

The **fatty acid mitochondrial transport system** refers collectively to the multi-step process and associated protein machinery responsible for importing long-chain fatty acids from the cytosol into the mitochondrial matrix, where they undergo β‐oxidation. This process is essential because long-chain fatty acids cannot cross the inner mitochondrial membrane unaided. The primary mechanism is known as the **carnitine shuttle**, which involves several key steps and proteins: 1. **Activation:** Long-chain fatty acids are first activated in the cytosol by long-chain acyl-CoA synthetase to form acyl-CoA[4]. 2. **CPT1:** On the outer mitochondrial membrane, carnitine palmitoyltransferase I (CPT1) catalyzes transfer of an acyl group from CoA to carnitine, forming acyl-carnitine[4][8]. 3. **Translocation:** Acyl-carnitines are transported across the inner mitochondrial membrane by carnitine-acylcarnitine translocase (CAC/SLC25A20), exchanging them with free carnitine moving out[4][8]. 4. **CPT2:** On the matrix side of the inner membrane, CPT2 transfers back the acyl group from carnitine onto CoA to regenerate intramitochondrial acyl-CoA ready for β‐oxidation[4][8]. This coordinated action enables efficient delivery of substrates required for ATP production via β‐oxidation and subsequent entry into citric acid cycle. **Note on correctness:** The term “fatty acid mitochondrial transport system” does *not* refer to a single molecular target or receptor but rather describes an integrated pathway involving multiple distinct enzymes and transporters—primarily CPT1, CAC/SLC25A20, and CPT2—as well as accessory molecules like L-carnitine[7]. Therefore it is not considered a canonical therapeutic target itself; instead its components can be individually targeted or studied. If you require structured information about one specific protein within this pathway—such as “Carnitine palmitoyltransferase 1” or “Carnitine-acylcarnitine translocase”—please specify that particular molecule so that detailed data can be provided accordingly[4][7][8].

Mechanism of Action

Biological Functions

Fatty acid import into mitochondria
Energy metabolism regulation
Beta oxidation facilitation

Disease Associations

Inherited metabolic disorders (e.g., carnitine deficiency syndromes)
Cardiomyopathy (in context of transporter deficiencies)[3]
Hypoketotic hypoglycemia[3]
Other energy metabolism disorders

Safety Considerations

No safety concerns listed